StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
2823
This month
10
This week
1
This year
99
Yesterday
1
Publishing Date
2022 - 12 - 08
16
2022 - 12 - 01
11
2022 - 11 - 10
19
2022 - 10 - 12
11
2022 - 10 - 06
12
2022 - 10 - 05
20
2022 - 09 - 22
10
2022 - 09 - 12
12
2022 - 06 - 21
9
2022 - 06 - 06
11
2022 - 05 - 19
9
2022 - 04 - 13
10
2022 - 04 - 12
10
2022 - 04 - 11
10
2022 - 04 - 08
29
2022 - 03 - 09
11
2022 - 03 - 08
37
2022 - 03 - 07
13
2022 - 03 - 01
9
2022 - 02 - 17
11
2022 - 02 - 14
9
2022 - 01 - 20
10
2022 - 01 - 19
9
2022 - 01 - 18
18
2021 - 12 - 13
10
2021 - 12 - 10
18
2021 - 12 - 09
18
2021 - 11 - 30
12
2021 - 11 - 12
17
2021 - 11 - 11
9
2021 - 11 - 09
15
2021 - 10 - 28
12
2021 - 10 - 25
11
2021 - 10 - 13
10
2021 - 10 - 07
19
2021 - 10 - 05
9
2021 - 10 - 04
12
2021 - 10 - 01
29
2021 - 09 - 30
14
2021 - 09 - 20
13
2021 - 09 - 14
10
2021 - 09 - 13
9
2021 - 09 - 07
9
2021 - 08 - 05
9
2021 - 07 - 27
9
2021 - 07 - 01
9
2021 - 06 - 17
9
2021 - 06 - 04
12
2021 - 06 - 03
11
2021 - 05 - 21
10
2021 - 05 - 20
15
2021 - 04 - 19
9
2021 - 04 - 13
9
2021 - 04 - 12
20
2021 - 04 - 10
16
2021 - 04 - 09
16
2021 - 04 - 08
11
2021 - 03 - 25
9
2021 - 03 - 10
17
2020 - 12 - 09
14
Sector
Administrative and support and waste management and remediation services
6
Commercial services
57
Communications
57
Consumer durables
4
Consumer non-durables
15
Consumer services
9
Distribution services
15
Electronic technology
16
Energy minerals
4
Finance
37
Finance and insurance
3
Health services
176
Health technology
2151
Industrial services
1
Information
1
Manufacturing
218
Mining, quarrying, and oil and gas extraction
4
N/a
51
Non-energy minerals
5
Process industries
7
Producer manufacturing
2
Professional, scientific, and technical services
77
Retail trade
9
Technology services
36
Transportation
2
Utilities
1
Wholesale trade
2
Tags
Acquisition
4244
Application
1781
Approval
1706
Awards
1448
Cancer
2823
Ceo
1673
Ces
4255
Collaboration
1769
Conference
14983
Contract
1510
Corporation
2443
Covid
2680
Covid-19
1834
Deadline
2004
Disease
1876
Distribution
2193
Drug
1968
Earnings
2846
Energy
4959
Europe
1748
Ev
1455
Events
3801
Fda
2323
Financial
2690
Financial results
8251
For
13399
Global
3929
Group
2282
Growth
7981
Health
3351
Iot
1741
Liver
1420
Market
11412
Media
1478
N/a
175064
Nasdaq
1892
Offering
5394
Partnership
1815
People
2010
Pharm-country
1493
Pharma
1536
Phase 2
1404
Platform
1415
Positive
2067
Presentation
2330
Program
2337
Report
8352
Research
7223
Results
26522
Sales
1567
Services
1445
System
1713
Technology
4147
Test
2086
Therapeutics
4901
Therapy
2201
Treatment
3622
Trial
5127
Update
1528
Vaccine
1617
Entities
Abbott laboratories
20
Abbvie inc.
36
Accuray incorporated
21
Agilent technologies, inc.
17
Amgen inc.
69
Anixa biosciences, inc.
28
Astellas pharma inc
22
Astrazeneca plc
94
Aveo pharmaceuticals, inc.
23
Becton, dickinson and company
18
Beigene, ltd.
47
Biocept, inc.
26
Blueprint medicines corporation
25
Briacell therapeutics corp.
25
Bristol-myers squibb company
79
Castle biosciences, inc.
19
Clovis oncology, inc.
31
Eli lilly and company
88
Epizyme, inc.
18
Exact sciences corporation
28
Exelixis, inc.
37
G1 therapeutics, inc.
19
Genprex, inc.
17
Gilead sciences, inc.
49
Glaxosmithkline plc
32
Guardant health, inc.
36
Hologic, inc.
20
Hoth therapeutics, inc.
20
Illumina, inc.
49
Immunitybio inc
22
Incyte corporation
46
Invitae corporation
18
Jaguar health, inc.
18
Johnson & johnson
76
Karyopharm therapeutics inc.
24
Lantern pharma inc.
20
Merck & company, inc.
48
Merus n.v.
18
Mirati therapeutics, inc.
25
Myriad genetics, inc.
25
Nanostring technologies, inc.
21
Natera, inc.
24
Nektar therapeutics
18
Novartis ag
61
Novocure limited
19
Oncolytics biotech inc.
27
Orange
57
Pds biotechnology corporation
22
Pfizer, inc.
40
Qiagen n.v.
23
Regeneron pharmaceuticals, inc.
38
Sanofi
140
Seagen inc.
38
Takeda pharmaceutical company limited
21
Thermo fisher scientific inc
31
Veracyte, inc.
26
Verastem, inc.
19
Veru inc.
18
Viewray, inc.
19
Y-mabs therapeutics, inc.
18
Symbols
ABBV
36
ABT
20
ALPMF
22
ALPMY
22
AMGN
69
ANIX
28
ARAY
21
AVEO
23
AZN
94
AZNCF
42
BCTX
25
BDX
18
BGNE
47
BIOC
26
BMY
79
BPMC
25
CLVS
31
CSTL
19
EPZM
18
EXAS
28
EXEL
37
FNCTF
57
GH
36
GILD
49
GLAXF
25
GSK
32
GTHX
19
HOLX
20
HOTH
20
IBRX
22
ILMN
49
INCY
46
JAGX
18
JNJ
76
KPTI
24
LLY
88
LTRN
20
MRK
48
MRTX
25
MRUS
18
MYGN
25
NKTR
18
NSTG
21
NTRA
24
NVCR
19
NVS
61
NVSEF
47
ONCY
27
PDSB
22
PFE
40
QGEN
23
REGN
38
SGEN
38
SNY
140
SNYNF
90
TAK
21
TMO
31
VCYT
26
VRAY
19
VSTM
19
Exchanges
Amex
45
Lse
27
Nasdaq
2488
Nyse
578
Tsx
18
Crawled Date
2022 - 12 - 09
9
2022 - 12 - 08
17
2022 - 12 - 01
11
2022 - 11 - 10
19
2022 - 11 - 08
9
2022 - 11 - 07
9
2022 - 10 - 12
11
2022 - 10 - 06
12
2022 - 10 - 05
20
2022 - 09 - 22
10
2022 - 09 - 12
13
2022 - 06 - 21
9
2022 - 06 - 06
11
2022 - 05 - 19
9
2022 - 04 - 13
10
2022 - 04 - 12
10
2022 - 04 - 11
10
2022 - 04 - 08
29
2022 - 03 - 09
13
2022 - 03 - 08
34
2022 - 03 - 07
13
2022 - 02 - 17
11
2022 - 02 - 14
9
2022 - 01 - 19
14
2022 - 01 - 18
12
2021 - 12 - 13
10
2021 - 12 - 10
20
2021 - 12 - 09
15
2021 - 11 - 30
12
2021 - 11 - 12
17
2021 - 11 - 09
14
2021 - 10 - 28
12
2021 - 10 - 25
11
2021 - 10 - 13
10
2021 - 10 - 07
19
2021 - 10 - 05
9
2021 - 10 - 04
12
2021 - 10 - 01
32
2021 - 09 - 30
11
2021 - 09 - 20
13
2021 - 09 - 14
10
2021 - 09 - 13
10
2021 - 09 - 07
9
2021 - 08 - 05
9
2021 - 06 - 17
9
2021 - 06 - 04
12
2021 - 06 - 03
11
2021 - 05 - 21
10
2021 - 05 - 20
14
2021 - 04 - 19
9
2021 - 04 - 13
10
2021 - 04 - 12
18
2021 - 04 - 10
15
2021 - 04 - 09
16
2021 - 04 - 08
11
2021 - 03 - 25
9
2021 - 03 - 21
11
2021 - 03 - 10
16
2020 - 12 - 09
14
2020 - 12 - 01
21
Crawled Time
00:00
50
00:20
12
01:00
50
02:00
15
03:00
8
04:00
4
04:20
2
05:00
11
06:00
20
06:03
2
07:00
23
08:00
27
08:20
2
09:00
32
10:00
29
11:00
125
11:33
3
12:00
292
12:01
2
12:03
4
12:05
2
12:06
2
12:15
61
12:20
65
12:30
34
13:00
304
13:01
6
13:02
3
13:04
6
13:05
3
13:15
61
13:20
79
13:30
44
14:00
263
14:01
5
14:03
3
14:15
22
14:20
35
14:30
42
15:00
139
15:01
3
15:15
12
15:20
23
15:30
13
16:00
103
16:20
35
17:00
81
18:00
85
19:00
84
20:00
72
20:20
8
21:00
93
21:03
3
22:00
118
22:01
5
22:04
6
22:14
3
22:15
6
22:17
3
23:00
84
Source
adnas.com
1
contravir.com
2
feed.businesswire.com
1
investor.alkermes.com
6
investor.aveooncology.com
2
investors.phiopharma.com
6
investors.senseibio.com
5
ir.anaptysbio.com
3
ir.biolinerx.com
2
ir.chemocentryx.com
1
ir.hoththerapeutics.com
4
ir.sunesis.com
1
ir.vaccinex.com
4
jaguarhealth.gcs-web.com
15
mdxhealth.com
3
nanthealth.com
2
renovorx.com
8
salariuspharma.com
1
spacfeed.com
1
www.4dpharmaplc.com
2
www.4frontventures.com
1
www.adnas.com
1
www.affimed.com
2
www.allogene.com
3
www.anpacbio.com
6
www.atossatherapeutics.com
2
www.beyondspringpharma.com
4
www.biospace.com
1420
www.celyad.com
2
www.chi-med.com
2
www.cuebiopharma.com
1
www.curevac.com
1
www.emmis.com
1
www.fatetherapeutics.com
9
www.fda.gov
30
www.gflenv.com
1
www.globenewswire.com
661
www.hepionpharma.com
2
www.hutch-med.com
2
www.igmbio.com
2
www.immatics.com
3
www.immunogen.com
4
www.immunoprecise.com
2
www.innodata.com
1
www.kuraoncology.com
9
www.limoneira.com
3
www.mdu.com
1
www.myriad.com
2
www.nanthealth.com
5
www.nantkwest.com
14
www.novocure.com
5
www.poseida.com
6
www.prnewswire.com
527
www.profoundmedical.com
1
www.rubiustx.com
1
www.sutrobio.com
8
www.teekay.com
1
www.theratech.com
1
www.thermogenesis.com
1
www.vermillion.com
4
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Cancer
save search
Health Equity Report Card Pilot Project to Help Close the Care Gap Highlighted on World Cancer Day
Published:
2023-02-04
(Crawled : 16:20)
- prnewswire.com
SNY
|
News
|
$46.02
-2.58%
-2.65%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$98.55
0
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$145.2
0.25%
0.0%
6.5M
|
Health Technology
|
Email alert
Add to watchlist
day
care
report
health
pilot
cancer
U.S. FDA Approves Trodelvy® in Pre-treated HR+/HER2- Metastatic Breast Cancer
Published:
2023-02-03
(Crawled : 19:00)
- biospace.com/
GILD
|
$84.51
3.83%
3.69%
13M
|
Health Technology
|
3.82%
|
O:
3.82%
H:
0.0%
C:
0.0%
trodelvy
fda
breast
cancer
GENE to Launch World’s First Comprehensive Risk Test for Breast & Ovarian Cancer
Published:
2023-02-03
(Crawled : 15:00)
- biospace.com/
GENE
2 d
|
$1.8
78.22%
43.89%
90M
|
Health Technology
|
69.85%
|
O:
69.85%
H:
0.0%
C:
0.0%
risk
for
test
breast
cancer
High Adoption Rate Of A New Treatment Against Cancer is likely to proliferate the Neuroendocrine Tumor Treatment CAGR: 10%|UnivDatos Market Insights
Published:
2023-02-03
(Crawled : 15:00)
- prnewswire.com
NVS
|
$85.85
-0.29%
-0.29%
3.9M
|
Health Technology
|
-0.05%
|
O:
-0.05%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$145.2
0.25%
0.0%
6.5M
|
Health Technology
|
1.05%
|
O:
1.05%
H:
0.0%
C:
0.0%
treatment
tumor
cancer
market
Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials
Published:
2023-02-03
(Crawled : 14:20)
- biospace.com/
MRNA
M
|
$173.27
-1.75%
-1.78%
2.8M
|
Health Technology
|
-1.39%
|
O:
-1.39%
H:
0.0%
C:
0.0%
PSNL
|
$3.92
28.95%
22.45%
7.8M
|
Health Technology
|
1.32%
|
O:
1.32%
H:
0.0%
C:
0.0%
trials
vaccine
mrna
agreement
cancer
White House Recognizes FINN Partners and OffScrip Health "Heartbreak in America's Heartland" Initiative; Aligns with Biden Administration's Cancer Moonshot
Published:
2023-02-02
(Crawled : 00:00)
- prnewswire.com
FNCTF
|
News
|
$9.745
-2.26%
|
Communications
|
Email alert
Add to watchlist
health
cancer
house
Verastem Oncology Outlines Key 2023 Strategic Priorities and Upcoming Catalysts for Advancing Avutometinib as a Backbone of Therapy for RAS Pathway-Driven Cancers
Published:
2023-02-02
(Crawled : 13:00)
- biospace.com/
VSTM
A
|
$0.7049
0.7%
0.7%
680K
|
Health Technology
|
9.98%
|
O:
5.61%
H:
7.11%
C:
4.14%
cancer
therapy
avutometinib
ras pathway
defactinib
lgsoc program
vs-6766
Mersana Therapeutics Initiates Expansion Portion of UPGRADE-A Combination Clinical Trial in Platinum-Sensitive Ovarian Cancer
Published:
2023-02-01
(Crawled : 15:00)
- biospace.com/
MRSN
|
$7.025
1.96%
1.92%
1.3M
|
Health Technology
|
4.71%
|
O:
0.15%
H:
3.03%
C:
1.97%
expansion
trial
therapeutics
cancer
Puma Biotechnology’s NERLYNX® Included in NCCN Clinical Practice Guidelines for the Treatment of Breast Cancer with a HER2 Mutation
Published:
2023-02-01
(Crawled : 14:00)
- biospace.com/
PBYI
|
$4.45
1.83%
1.8%
540K
|
Health Technology
|
0.92%
|
O:
0.23%
H:
2.07%
C:
0.23%
nerlynx
guidelines
treatment
for
breast
cancer
Gilead Awards $7.6 Million in Grants to Advance Health Equity in Breast Cancer
Published:
2023-02-01
(Crawled : 14:00)
- biospace.com/
GILD
|
$84.51
3.83%
3.69%
13M
|
Health Technology
|
1.26%
|
O:
0.67%
H:
0.77%
C:
-0.01%
awards
breast
health
grants
cancer
Guardant Health introduces Guardant GalaxyTM suite of advanced AI analytics to enhance its portfolio of cancer tests and accelerate biomarker discovery
Published:
2023-01-31
(Crawled : 14:00)
- biospace.com/
GH
|
$31.92
-1.45%
-1.47%
1.9M
|
Health Services
|
3.45%
|
O:
-0.89%
H:
3.45%
C:
1.29%
analytics
health
biomarker
cancer
Context Therapeutics’ Clinical Partner Stemline Therapeutics, a Subsidiary of Menarini Group Receives FDA Approval of ORSERDU™ (elacestrant) in ER+, HER2-, ESR1-mutated Breast Cancer
Published:
2023-01-31
(Crawled : 13:20)
- biospace.com/
CNTX
|
$0.9168
-7.39%
-7.98%
450K
|
Health Technology
|
42.86%
|
O:
74.29%
H:
27.05%
C:
-13.11%
fda
breast
approval
cancer
group
elascestrant
orserdu
ona-xr
her2-
Working With Cancer: from Davos to the Super Bowl
Published:
2023-01-31
(Crawled : 13:20)
- globenewswire.com
SNY
|
News
|
$46.02
-2.58%
-2.65%
3.5M
|
Health Technology
|
-6.21%
|
O:
-0.35%
H:
0.0%
C:
0.0%
cancer
The Caris Precision Oncology Alliance Welcomes The UCI Health Chao Family Comprehensive Cancer Center
Published:
2023-01-31
(Crawled : 12:00)
- prnewswire.com
FNCTF
|
News
|
$9.745
-2.26%
|
Communications
|
Email alert
Add to watchlist
health
cancer
Federal Appellate Court Rejects Controversial J&J Ploy to Dodge Talc Cancer Lawsuits
Published:
2023-01-30
(Crawled : 23:00)
- prnewswire.com
JNJ
|
News
|
$164.61
-0.56%
-0.01%
6.8M
|
Health Technology
|
-1.34%
|
O:
-3.75%
H:
0.0%
C:
0.0%
cancer
TROPION-Lung07 Phase 3 Trial Initiated to Evaluate Datopotamab Deruxtecan in Combination with Pembrolizumab in Patients with Previously Untreated Metastatic Non-Small Cell Lung Cancer
Published:
2023-01-30
(Crawled : 14:00)
- biospace.com/
AZN
|
$63.45
0.48%
0.47%
4.8M
|
Health Technology
|
-2.66%
|
O:
1.45%
H:
0.0%
C:
0.0%
lung
trial
cancer
initiated
Aethlon Medical Announces Contract with NAMSA to Advance Hemopurifier Clinical Programs in Cancer
Published:
2023-01-30
(Crawled : 13:20)
- prnewswire.com
AEMD
|
$0.6276
-4.91%
-5.16%
630K
|
Health Technology
|
55.15%
|
O:
27.49%
H:
0.0%
C:
0.0%
medical
contract
cancer
hemopurifier
Beyond Cancer® Appoints Gavin Choy, PharmD as Chief Operating Officer
Published:
2023-01-30
(Crawled : 13:20)
- biospace.com/
XAIR
|
$7.22
7.12%
6.65%
440K
|
Technology Services
|
1.69%
|
O:
0.31%
H:
0.0%
C:
0.0%
cancer
Guardant Health receives FDA approval for Guardant360® CDx as companion diagnostic for Menarini Group’s ORSERDU™ for treatment of patients with ESR1 mutations in ER+, HER2- advanced or metastatic breast cancer
Published:
2023-01-30
(Crawled : 13:00)
- biospace.com/
GH
|
$31.92
-1.45%
-1.47%
1.9M
|
Health Services
|
5.47%
|
O:
1.95%
H:
0.0%
C:
0.0%
guardant360
treatment
fda
for
diagnostic
breast
health
approval
cancer
esr1 mutation
orserdu
her2-
Stemline Therapeutics Receives U.S. FDA Approval for ORSERDUTM (elacestrant) as the First and Only Treatment Specifically Indicated for Patients with ESR1 Mutations in ER+, HER2- Advanced or Metastatic Breast Cancer
Published:
2023-01-30
(Crawled : 13:00)
- biospace.com/
RDUS
|
$10.08
0.0%
|
Health Technology
|
Email alert
Add to watchlist
treatment
fda
for
breast
approval
therapeutics
cancer
orserdutm
elacestrant
esr1 mutation
elascestrant
her2-
← Previous
1
2
3
4
5
6
7
8
9
…
141
142
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.